Keyphrases
Acute Myeloid Leukemia
19%
Acute Myocardial Infarction
17%
Adjusted Odds Ratio
11%
Adverse Events
18%
AIDS/HIV
15%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
17%
Alzheimer's Disease
13%
Amino Acids
11%
Antibiotics
11%
Antiretroviral Therapy
14%
Apoptosis
16%
Asthma
13%
B Cells
14%
Bone Marrow
12%
Breast Cancer
20%
Ca2+
12%
Cardiovascular Disease
21%
CD8+ T Cells
13%
Chemotherapy
22%
Chronic Kidney Disease
16%
Clinical Outcomes
26%
Clinical Trials
28%
Comorbidity
11%
Confidence Interval
71%
Coronary Artery Disease
14%
COVID-19
40%
Dendritic Cells
18%
Diabetes
26%
Disease Progression
11%
Escherichia Coli
11%
Fatty Acids
11%
Gene Expression
28%
Gene-deficient Mice
12%
Granulocyte Colony-stimulating Factor (G-CSF)
14%
Hazard Ratio
24%
Heart Failure
42%
Hematopoietic Stem Cells
14%
High Risk
24%
Hospitalization
17%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
Hypertension
16%
Immune Response
17%
In Cancer
16%
Inflammation
27%
Inflammatory Bowel Disease
12%
Insulin
20%
Insulin Resistance
12%
Integrin
14%
Intensive Care Unit
11%
Interferon-α (IFN-α)
17%
Interleukin-1β
16%
Kidney
20%
Left Ventricular Function
17%
Lipids
13%
Liver
19%
Lung
21%
Lung Transplantation
18%
Macrophages
36%
Meta-analysis
23%
Metabolism
12%
Monoclonal Antibody
17%
Mouse Model
20%
Multiple Myeloma
17%
Myocardial Infarction
19%
Natural Killer Cells
30%
Neutrophils
16%
Non-small Cell Lung Cancer (NSCLC)
13%
Obesity
23%
Odds Ratio
27%
Older Adults
31%
Osteoclast
15%
Overall Survival
25%
Overexpression
14%
Parkinson's Disease
12%
Patients with Heart Failure
11%
People Living with HIV (PLHIV)
12%
Percutaneous Coronary Intervention
11%
Phase II Study
17%
Phase II Trial
16%
Phosphorylation
16%
Placebo
21%
Progression-free Survival
13%
Quality of Life
15%
Randomized Clinical Trial
12%
Randomized Controlled Trial
19%
Randomized Trial
11%
Relapsed or Refractory
12%
Risk Factors
28%
Systematic Meta-analysis
13%
T Cells
43%
Transcription Factor
16%
Transgenic Mice
11%
Transplantation
15%
Tumor
42%
Tumor Necrosis Factor-α
14%
Type 1 Diabetes Mellitus (T1DM)
16%
Type 2 Diabetes Mellitus (T2DM)
18%
United States
38%
Virus
22%
Weight Loss
11%
Medicine and Dentistry
Acute Heart Infarction
10%
Acute Kidney Injury
9%
Acute Myeloid Leukemia
13%
Adverse Event
21%
Allograft
9%
Antiretroviral Therapy
9%
Apoplexy
13%
Arm
13%
Asthma
9%
Atrial Fibrillation
8%
B Cell
9%
Biological Marker
21%
Biopsy Technique
11%
Bleeding
8%
Body Mass Index
10%
Breast Cancer
31%
Calcium Ion
8%
Cancer
21%
Carcinogenesis
8%
Cardiovascular Disease
23%
Cardiovascular System
28%
Chronic Kidney Disease
14%
Clinical Trial
28%
Clinician
20%
Cohort Analysis
13%
Cohort Effect
12%
Colorectal Carcinoma
8%
Combination Therapy
12%
Comorbidity
12%
Congestive Heart Failure
49%
Coronary Artery Disease
11%
COVID-19
34%
Cross Sectional Study
9%
Cytokine
11%
Diabetes
27%
Diabetes Mellitus
11%
Disease
10%
Diseases
100%
Echocardiography
9%
Emergency Department
13%
Epithelial Cell
10%
Gene Expression
13%
Hazard Ratio
19%
Health Care
13%
Health Care Cost
22%
Hematopoietic Cell
17%
Homeostasis
8%
Human Immunodeficiency Virus
39%
Immunotherapy
11%
In Vitro
21%
Infection
47%
Intensive Care Unit
12%
Isotopes of Calcium
9%
Logistic Regression Analysis
10%
Lung
26%
Lung Cancer
10%
Lung Transplantation
15%
Lymphocyte
8%
Macrophage
16%
Magnetic Resonance Imaging
10%
Malignant Neoplasm
43%
Maturity Onset Diabetes of the Young
12%
Medicare
16%
Medicine
10%
Melanoma
8%
Messenger RNA
13%
Meta-Analysis
17%
Metastatic Carcinoma
14%
Multiple Myeloma
15%
Myocardial Infarction
15%
Neoplasm
55%
Nephropathy
10%
Non Small Cell Lung Cancer
11%
Odds Ratio
27%
Oncology
16%
Outpatient
11%
Overall Survival
26%
Pathogen
10%
Pediatrics
14%
Percutaneous Coronary Intervention
10%
Placebo
15%
Prevalence
24%
Primary Health Care
11%
Programmed Cell Death
9%
Progression Free Survival
13%
Public Health
9%
Quality of Life
18%
Radiation Therapy
12%
Randomized Clinical Trial
8%
Randomized Controlled Trial
16%
Receptor
19%
Recurrent Disease
12%
Rituximab
8%
Sepsis
8%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Stem Cell
10%
Systematic Review
21%
T Cell
18%
Targeted Therapy
8%
Tumor Necrosis Factor
10%